TNF-Alpha Inhibitors (REGENXBIO)

N/A

Report date: 2025/01/26 16:21:25

Base Information

Drug NameTNF-Alpha Inhibitors (REGENXBIO)
Drug Alias NameAAV8-Delivered TNF-Alpha Inhibitors (REGENXBIO)
ClassificationBiologics
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsUveitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRegenxbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesRegenxbio Inc
Inactive CompaniesN/A
Active IndicationsUveitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A